AR049063A1 - Composiciones farmaceuticas inyectables de posaconazol con particulas estabilizadas - Google Patents
Composiciones farmaceuticas inyectables de posaconazol con particulas estabilizadasInfo
- Publication number
- AR049063A1 AR049063A1 ARP050102203A ARP050102203A AR049063A1 AR 049063 A1 AR049063 A1 AR 049063A1 AR P050102203 A ARP050102203 A AR P050102203A AR P050102203 A ARP050102203 A AR P050102203A AR 049063 A1 AR049063 A1 AR 049063A1
- Authority
- AR
- Argentina
- Prior art keywords
- posaconazol
- pharmaceutical compositions
- injectable pharmaceutical
- stabilized particles
- stabilized
- Prior art date
Links
- RAGOYPUPXAKGKH-XAKZXMRKSA-N posaconazole Chemical compound O=C1N([C@H]([C@H](C)O)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@H]3C[C@@](CN4N=CN=C4)(OC3)C=3C(=CC(F)=CC=3)F)=CC=2)C=C1 RAGOYPUPXAKGKH-XAKZXMRKSA-N 0.000 title abstract 2
- 229960001589 posaconazole Drugs 0.000 title abstract 2
- 239000002245 particle Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 238000009472 formulation Methods 0.000 abstract 2
- 239000007853 buffer solution Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229940102213 injectable suspension Drugs 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 230000001012 protector Effects 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57512604P | 2004-05-28 | 2004-05-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR049063A1 true AR049063A1 (es) | 2006-06-21 |
Family
ID=34971355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050102203A AR049063A1 (es) | 2004-05-28 | 2005-05-27 | Composiciones farmaceuticas inyectables de posaconazol con particulas estabilizadas |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1761247A1 (ja) |
JP (1) | JP2008501034A (ja) |
KR (1) | KR20070027564A (ja) |
CN (1) | CN1988887A (ja) |
AR (1) | AR049063A1 (ja) |
AU (1) | AU2005249502A1 (ja) |
CA (1) | CA2567803A1 (ja) |
IL (1) | IL179627A0 (ja) |
MX (1) | MXPA06013886A (ja) |
NO (1) | NO20066005L (ja) |
PE (1) | PE20060291A1 (ja) |
RU (1) | RU2006146555A (ja) |
TW (1) | TWI290051B (ja) |
WO (1) | WO2005117831A1 (ja) |
ZA (1) | ZA200609890B (ja) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060009469A1 (en) * | 2004-05-28 | 2006-01-12 | Leonore Witchey-Lakshmanan | Particulate-stabilized injectable pharmacutical compositions of posaconazole |
SI2018164T1 (sl) | 2006-05-12 | 2017-07-31 | Christian Noe | Uporaba kombinacijskih pripravkov, ki obsegajo antimikotike |
EP2130540A1 (en) * | 2008-06-02 | 2009-12-09 | Sandoz AG | Pharmaceutical compositions containing a crystalline form of posaconazole |
EP2141159A1 (en) | 2008-07-03 | 2010-01-06 | Sandoz AG | A Crystalline form of posaconazole |
EP2451805A1 (en) | 2009-07-09 | 2012-05-16 | Sandoz AG | A crystalline form of posaconazole |
AU2011254654B2 (en) | 2010-05-19 | 2016-01-07 | Sandoz Ag | Process for the preparation of chiral triazolones |
EP2571847B1 (en) | 2010-05-19 | 2016-09-21 | Sandoz AG | Process for the preparation of chiral hydrazides |
WO2011144657A1 (en) | 2010-05-19 | 2011-11-24 | Sandoz Ag | Purification of posaconazole and posaconazole intermediates |
CA2798007C (en) | 2010-05-19 | 2018-10-23 | Sandoz Ag | Preparation of posaconazole intermediates |
JP6008849B2 (ja) | 2010-06-29 | 2016-10-19 | メルク・シャープ・エンド・ドーム・コーポレイション | 置換β−シクロデキストリンにより安定化されたポサコナゾール静脈注射用溶液製剤 |
WO2012172015A1 (en) | 2011-06-16 | 2012-12-20 | Sandoz Ag | Process for the preparation of a chiral compound |
CN103284959B (zh) * | 2012-02-22 | 2015-06-03 | 重庆圣华曦药业股份有限公司 | 泊沙康唑冻干粉针剂及制备方法 |
CN102755628B (zh) * | 2012-07-16 | 2013-10-23 | 中国科学院微生物研究所 | 一种抗真菌的药物组合物 |
CN102805731B (zh) * | 2012-08-22 | 2014-04-30 | 北京莱瑞森医药科技有限公司 | 泊沙康唑干混悬剂及其制备方法 |
CN105030668B (zh) * | 2015-06-26 | 2018-03-27 | 济川药业集团有限公司 | 泊沙康唑口服混悬剂及其制备方法 |
CN106333925B (zh) * | 2015-07-10 | 2019-06-18 | 上海美悦生物科技发展有限公司 | 一种泊沙康唑液体混悬剂及其制备方法 |
CN105997872B (zh) * | 2016-07-08 | 2019-02-19 | 河南省立眼科医院 | 一种含有泊沙康唑的眼用纳米胶束抗真菌溶液 |
MX2019011603A (es) * | 2017-03-26 | 2021-08-16 | Robyn Vivi Stafford | Metodo de tratamiento de las condiciones de la piel de los parpados. |
KR20200059188A (ko) * | 2017-04-12 | 2020-05-28 | 비카쉬 제이. 바그완딘 | 내성 종양의 민감화를 위해 포사코나졸을 사용한 조성물, 패키징된 약제, 및 방법 |
CN110507609B (zh) * | 2018-05-21 | 2021-09-17 | 上海医药工业研究院 | 泊沙康唑口服混悬剂的制备方法 |
CN111514146A (zh) * | 2020-04-28 | 2020-08-11 | 山西振东泰盛制药有限公司 | 含有泊沙康唑的药物组合物 |
CN113933131B (zh) * | 2021-09-24 | 2024-01-26 | 合肥天一生物技术研究所有限责任公司 | 一种阴道微生物荧光染色液 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5091188A (en) * | 1990-04-26 | 1992-02-25 | Haynes Duncan H | Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
MXPA03009021A (es) * | 2001-04-03 | 2004-02-12 | Schering Corp | Composicion antifungal con biodisponibilidad aumentada. |
-
2005
- 2005-05-27 AU AU2005249502A patent/AU2005249502A1/en not_active Abandoned
- 2005-05-27 RU RU2006146555/15A patent/RU2006146555A/ru not_active Application Discontinuation
- 2005-05-27 EP EP05755118A patent/EP1761247A1/en not_active Withdrawn
- 2005-05-27 CN CNA2005800248542A patent/CN1988887A/zh active Pending
- 2005-05-27 KR KR1020067024996A patent/KR20070027564A/ko not_active Application Discontinuation
- 2005-05-27 MX MXPA06013886A patent/MXPA06013886A/es unknown
- 2005-05-27 JP JP2007515456A patent/JP2008501034A/ja not_active Withdrawn
- 2005-05-27 TW TW094117524A patent/TWI290051B/zh not_active IP Right Cessation
- 2005-05-27 PE PE2005000599A patent/PE20060291A1/es not_active Application Discontinuation
- 2005-05-27 AR ARP050102203A patent/AR049063A1/es not_active Application Discontinuation
- 2005-05-27 WO PCT/US2005/018945 patent/WO2005117831A1/en active Application Filing
- 2005-05-27 CA CA002567803A patent/CA2567803A1/en not_active Abandoned
-
2006
- 2006-11-27 ZA ZA200609890A patent/ZA200609890B/xx unknown
- 2006-11-27 IL IL179627A patent/IL179627A0/en unknown
- 2006-12-22 NO NO20066005A patent/NO20066005L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20070027564A (ko) | 2007-03-09 |
NO20066005L (no) | 2007-02-27 |
JP2008501034A (ja) | 2008-01-17 |
EP1761247A1 (en) | 2007-03-14 |
PE20060291A1 (es) | 2006-04-14 |
TWI290051B (en) | 2007-11-21 |
RU2006146555A (ru) | 2008-07-20 |
MXPA06013886A (es) | 2007-01-26 |
ZA200609890B (en) | 2008-09-25 |
CN1988887A (zh) | 2007-06-27 |
TW200609001A (en) | 2006-03-16 |
CA2567803A1 (en) | 2005-12-15 |
WO2005117831A1 (en) | 2005-12-15 |
IL179627A0 (en) | 2007-05-15 |
AU2005249502A1 (en) | 2005-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR049063A1 (es) | Composiciones farmaceuticas inyectables de posaconazol con particulas estabilizadas | |
CL2015001974A1 (es) | (divisional de la sol. 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos. | |
UY31209A1 (es) | Uso de homo y copolimeros para la estabilización de formulaciones de principios activos | |
AR059350A1 (es) | Formulacion farmaceutica para aerosoles con dos o mas principios activos y al menos una sustancia tensioactiva | |
CL2009001874A1 (es) | Uso de bacillus subtilis qst713 nrrl b-21661 para formular una composición probiótica para un animal; y composición probiotica de bacillus subtilis qst713 nrrl b-21661. | |
BRPI0508540A (pt) | composto, composição farmacêutica, e, uso de um composto | |
MX2009003030A (es) | Forma galenita para la administracion por via transmucosa de principios activos. | |
AR064614A1 (es) | Producto combinado par controlar parasitos en animales | |
BR112015023922A2 (pt) | composição farmacêutica compreendendo um ativador de ampk e um agente serotonérgico e métodos de uso destes | |
RS51185B (sr) | Kompozicije za vaginalnu primenu | |
BRPI0714417B8 (pt) | método para fabricar uma composição de cuidado oral, de cuidado pessoal, limpadora e/ou de cuidado doméstico | |
AR043863A1 (es) | Composiciones que contienen piperacilina y tazobactam, utiles para inyeccioines | |
CL2018001420A1 (es) | Tratamiento de trastornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma. (divisional solicitud 201701853) | |
DE602006014990D1 (de) | Intranasale verabreichung von schnell wirkendem insulin | |
ES2722201T3 (es) | Composiciones y procedimientos útiles para estabilizar formulaciones que contienen proteínas | |
BRPI1009842B8 (pt) | uso de agonista de tlr9 e agonista de tlr2/6 na preparação de uma composição farmacêutica para tratamento, inibição ou atenuação de uma infecção microbiana, bem como composição farmaceuticamente aceitável compreendendo os referidos agonistas | |
ECSP077387A (es) | Composiciones que contienen piperacilina, tazobactam y un ácido aminocarboxílico en un diluyente de lactato de sodio | |
AR052162A1 (es) | Composiciones farmaceuticas inyectables estabilizadas con particulados de posaconazol | |
FI964285A (fi) | Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet | |
BR112015005347A2 (pt) | composto, composição farmacêutica, e, método para tratamento ou profilaxia de infecção por hiv ou para tratamento, profilaxia, ou atraso no início de aids | |
BRPI0614197B8 (pt) | composição farmaceuticamente eficaz em uma forma farmacêutica para administração peroral contendo pelo menos um dos ingredientes ativos indometacina e acemetacina, formas de administração, e, uso da composição | |
EA200801614A1 (ru) | Фармацевтическая композиция, содержащая монтелукаст | |
DE60232271D1 (de) | Wässrige pharmazeutische formulierungen von wasserlöslichen prodrugs von propofol-verbindungen | |
DK1974721T3 (da) | Injiceringsdygtig steril farmaceutisk sammensætning med natriumpiperacillin og natriumtazobactam som aktive stoffer | |
CY1120050T1 (el) | Φαρμακοτεχνικες μορφες για την αποδεσμευση δραστικων ενωσεων |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |